<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141652974482500%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903019%26RESULT%3d1%26SIGN%3dIjsHhocI6x%252fe%252fYHkUeDB7YshHLg%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903019&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903019&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903019&amp;v=MTMxNjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVjc3SlBUWE1aYkc0SDlqTXJJOUViWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#35" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#36" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#38" data-title="1.2 研究方法">1.2 研究方法</a></li>
                                                <li><a href="#40" data-title="1.3 检测方法">1.3 检测方法</a></li>
                                                <li><a href="#42" data-title="1.4 统计学处理">1.4 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#45" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#46" data-title="2.1 两组一般临床资料比较">2.1 两组一般临床资料比较</a></li>
                                                <li><a href="#52" data-title="2.2 Logistic单因素回归分析">2.2 Logistic单因素回归分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#55" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#48" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者一般资料比较&lt;/b&gt;"><b>表</b>1 <b>两组患者一般资料比较</b></a></li>
                                                <li><a href="#49" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;应用造影剂后两组肾功能水平比较&lt;/b&gt;&lt;mathml id=&quot;50&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>应用造影剂后两组肾功能水平比较</b><mathml id="50"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#51" data-title="&lt;b&gt;表&lt;/b&gt;3 CIN&lt;b&gt;发生率比较&lt;/b&gt;"><b>表</b>3 CIN<b>发生率比较</b></a></li>
                                                <li><a href="#54" data-title="&lt;b&gt;表&lt;/b&gt;4 CIN&lt;b&gt;的多因素&lt;/b&gt;Logistic&lt;b&gt;回归分析&lt;/b&gt;"><b>表</b>4 CIN<b>的多因素</b>Logistic<b>回归分析</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Schindler R, Stahl C, Venz S, et al.Removal of contrast media by different extracororeal treatments[J].Nephrol Dial Transplant, 2001, 16 (7) ;1471-1474." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Removal of contrast media by different extracorporeal treatments">
                                        <b>[1]</b>
                                        Schindler R, Stahl C, Venz S, et al.Removal of contrast media by different extracororeal treatments[J].Nephrol Dial Transplant, 2001, 16 (7) ;1471-1474.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="王华平, 刘金华, 任强.糖化血红蛋白和尿微量清蛋白与糖尿病肾病关系的探讨[J].检验医学与临床, 2010, 7 (24) :2747-2748." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201024034&amp;v=MjkzODl1Wm1GeWpsVjc3Skx6VFNZckc0SDlIT3E0OUdZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        王华平, 刘金华, 任强.糖化血红蛋白和尿微量清蛋白与糖尿病肾病关系的探讨[J].检验医学与临床, 2010, 7 (24) :2747-2748.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="冯霞.造影剂肾病发病机制及防治研究进展[J].中华实用诊断与治疗杂志, 2010, 24 (9) :835-837." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HNZD201009002&amp;v=MTc3MzE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVjc3SkxTUFJhckc0SDlITXBvOUZab1FLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        冯霞.造影剂肾病发病机制及防治研究进展[J].中华实用诊断与治疗杂志, 2010, 24 (9) :835-837.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Toprak O.Risk Markers for Contrast-induced Nephropathy[J].Am J Med Sci, 2007, 334 (4) :283-290." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK121016052293&amp;v=MjgzNjl1a0dEeE04enhVU21EZDlTSDduM3hFOWZidm5LcmlmWmVadkZ5bnRVNy9JSkY4Vk5pZmNaYks2SDlITnFZOUFa&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        Toprak O.Risk Markers for Contrast-induced Nephropathy[J].Am J Med Sci, 2007, 334 (4) :283-290.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Kumar S, Nair RK, Aggarwal N, et al.Risk factors for contrast-induced nephropathy after coronary angiography[J].Saudi J Kidney Dis Transpl, 2017, 28 (2) :318-324." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK698AAFD2C398103818A43985DAA5EE91&amp;v=MjIzNDFMVTA1dEJoeExpN3dhaz1OaWZjWmJXeEZxQzkyZnRIRitnR0JIMDV6QjRTNGs1NVMzYnFxV1pFQ0xmaE1MT2VDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        Kumar S, Nair RK, Aggarwal N, et al.Risk factors for contrast-induced nephropathy after coronary angiography[J].Saudi J Kidney Dis Transpl, 2017, 28 (2) :318-324.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Calvin AD, Misra S, Pflueger A.Contrast-induced acute kidney injury and diabetic nephropathy[J].Nat Rev Nephrol, 2010, 6 (11) :679-688." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Contrast-induced acute kidney injury and diabetic nephropathy">
                                        <b>[6]</b>
                                        Calvin AD, Misra S, Pflueger A.Contrast-induced acute kidney injury and diabetic nephropathy[J].Nat Rev Nephrol, 2010, 6 (11) :679-688.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Huber W, Huber T, Baum S, et al.Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline:A Randomized Controlled Trial[J].Medicine (Baltimore) , 2016, 95 (21) :e3720." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWKF1D8D075A17306AA9D4BDA2CB6BD5015&amp;v=MjIyMTBBekM4YVJSYnVhQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExpN3dhaz1OaWZjWmNXNWF0bTRyNGhBRmVvSUQzdy92bWNhbmpzUFBBN2czMg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        Huber W, Huber T, Baum S, et al.Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline:A Randomized Controlled Trial[J].Medicine (Baltimore) , 2016, 95 (21) :e3720.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Zapata-Chica CA, Bello Marquez D, Serna-Higuita LM, et al.Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy:a systematic review and meta-analysis[J].Colomb Med (Cali) , 2015, 46 (3) :90-103." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy:a systematic review and metaanalysis">
                                        <b>[8]</b>
                                        Zapata-Chica CA, Bello Marquez D, Serna-Higuita LM, et al.Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy:a systematic review and meta-analysis[J].Colomb Med (Cali) , 2015, 46 (3) :90-103.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="Nieto-Rios JF, Salazar WA, S&#225;nchez OM, et al.Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) [J].J Bras Nefrol, 2014, 36 (3) :360-366." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study)">
                                        <b>[9]</b>
                                        Nieto-Rios JF, Salazar WA, S&#225;nchez OM, et al.Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) [J].J Bras Nefrol, 2014, 36 (3) :360-366.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Niki E.Action of ascorbic acid as a scavenger of active and stable oxygen radicals[J].Am J Clin Nutr, 1991, 54 (6Suppl) :1119s-1124s." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Action of ascorbic acid as a scavenger of active and stable oxygen radicals">
                                        <b>[10]</b>
                                        Niki E.Action of ascorbic acid as a scavenger of active and stable oxygen radicals[J].Am J Clin Nutr, 1991, 54 (6Suppl) :1119s-1124s.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Dvoršak B, Kani&lt;mathml id=&quot;27&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mover&gt;&lt;mstyle mathsize=&quot;140%&quot; displaystyle=&quot;true&quot;&gt;&lt;mtext&gt;c&lt;/mtext&gt;&lt;/mstyle&gt;&lt;mo&gt;ˇ&lt;/mo&gt;&lt;/mover&gt;&lt;mspace width=&quot;0.25em&quot; /&gt;&lt;mtext&gt;V&lt;/mtext&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;E&lt;/mtext&gt;&lt;mtext&gt;k&lt;/mtext&gt;&lt;mtext&gt;a&lt;/mtext&gt;&lt;mtext&gt;r&lt;/mtext&gt;&lt;mtext&gt;t&lt;/mtext&gt;&lt;mspace width=&quot;0.25em&quot; /&gt;&lt;mtext&gt;R&lt;/mtext&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;, et al.Ascorbic Acid for the prevention of contrast- induced nephropathy after coronary angiography in patients with chronic renal impairment:a randomized controlled trial[J].Ther Apher Dial, 2013, 17 (4) :384-390." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD13082100010207&amp;v=MTM2MTFPcm85RlpPb1BEbncrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0UWF4TT1OaWZjYXJLN0h0bg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Dvoršak B, Kani&lt;mathml id=&quot;27&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mover&gt;&lt;mstyle mathsize=&quot;140%&quot; displaystyle=&quot;true&quot;&gt;&lt;mtext&gt;c&lt;/mtext&gt;&lt;/mstyle&gt;&lt;mo&gt;ˇ&lt;/mo&gt;&lt;/mover&gt;&lt;mspace width=&quot;0.25em&quot; /&gt;&lt;mtext&gt;V&lt;/mtext&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;E&lt;/mtext&gt;&lt;mtext&gt;k&lt;/mtext&gt;&lt;mtext&gt;a&lt;/mtext&gt;&lt;mtext&gt;r&lt;/mtext&gt;&lt;mtext&gt;t&lt;/mtext&gt;&lt;mspace width=&quot;0.25em&quot; /&gt;&lt;mtext&gt;R&lt;/mtext&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;, et al.Ascorbic Acid for the prevention of contrast- induced nephropathy after coronary angiography in patients with chronic renal impairment:a randomized controlled trial[J].Ther Apher Dial, 2013, 17 (4) :384-390.
                                    </a>
                                </li>
                                <li id="28">


                                    <a id="bibliography_12" title="Cetin M, Devrim E, Serin Kili&#231;oglu S, et al.Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue:partial protective role of ascorbic acid[J].Ren Fail, 2008, 30 (5) :567-572." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJIH&amp;filename=SJIH15082600301405&amp;v=MTE1MjNQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGNFFheE09TmlmQ1pySzlIdG5PcVk5Rlorc09DSHc4b0JNVDZUNA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        Cetin M, Devrim E, Serin Kili&#231;oglu S, et al.Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue:partial protective role of ascorbic acid[J].Ren Fail, 2008, 30 (5) :567-572.
                                    </a>
                                </li>
                                <li id="30">


                                    <a id="bibliography_13" title="Spargias K, Alexopoulos E, Kyrzopoulos S, et al.Ascorbic acid prevents contrast- mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J].Circulation, 2004, 110 (18) :2837-2842." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000031523&amp;v=MjAyNzE2SDlIUHI0OUZaT2dPQ1g0Nm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGNFFheE09TmlmY1piSw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Spargias K, Alexopoulos E, Kyrzopoulos S, et al.Ascorbic acid prevents contrast- mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J].Circulation, 2004, 110 (18) :2837-2842.
                                    </a>
                                </li>
                                <li id="32">


                                    <a id="bibliography_14" title="Komiyama K, Ashikaga T, Inagaki D, et al.Sodium Bicarbonate-Ascorbic Acid Combination for Prevention of Contrast-Induced Nephropathy in Chronic Kidney Disease Patients Undergoing Catheterization[J].Circ J, 2017, 81 (2) :235-240." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Sodium bicarbonate-ascorbic acid combination for prevention of contrast-induced nephropathy in chronic kidney disease patients undergoing catheterization">
                                        <b>[14]</b>
                                        Komiyama K, Ashikaga T, Inagaki D, et al.Sodium Bicarbonate-Ascorbic Acid Combination for Prevention of Contrast-Induced Nephropathy in Chronic Kidney Disease Patients Undergoing Catheterization[J].Circ J, 2017, 81 (2) :235-240.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),333-336 DOI:10.3969/j.issn.1008-0074.2019.03.18            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>碳酸氢钠联合维生素</b>C<b>对早期糖尿病肾病患者</b>PCI<b>造影剂肾病的预防作用</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="javascript:;">张鹏</a>
                                <a href="javascript:;">张瑞妮</a>
                                <a href="javascript:;">李飞</a>
                                <a href="javascript:;">高峰</a>
                                <a href="javascript:;">曹杰</a>
                </h2>
                    <h2>

                    <span>延安大学附属医院心脑血管专科病区心内科</span>
                    <span>延安大学附属医院心脑血管专科病区检验科</span>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨碳酸氢钠联合维生素C对于早期糖尿病肾病 (DN) 患者经皮冠脉介入治疗 (PCI) 时造影剂肾病 (CIN) 的预防作用。<b>方法</b>:选择2014年9月至2016年7月我科收治的420例冠心病合并早期DN患者, 随机均分为常规介入组和联合治疗组 (在常规介入组基础上接受碳酸氢钠联合抗坏血酸治疗) , 两组均接受PCI和生理盐水水化治疗。测量并比较两组应用造影剂后的血肌酐 (SCr) 、肾小球滤过率 (GFR) 、肌酐清除率 (Ccr) 和尿素氮 (BUN) 水平, CIN发生率, 并分析影响CIN发生的独立危险因素。<b>结果</b>:应用造影剂后, 与常规介入组比较, 联合治疗组SCr[ (110.32±12.35) μmol/L比 (100.30±9.73) μmol/L]和BUN[ (11.23±2.43) mmol/L比 (7.16±3.14) mmol/L]水平均显著降低, GFR[ (30.67±9.56) ml·min<sup>-1</sup>·1.73m<sup>-2</sup>比 (37.26±7.69) ml·min<sup>-1</sup>·1.73m<sup>-2</sup>]和Ccr[ (62.31±19.73) ml/min比 (68.07±21.48) ml/min]均显著升高, <i>P</i>均&lt;0.01;联合治疗组SCr升高≥44.2μmol/L (6.7%比1.9%) 和SCr升高≥25% (9.0%比2.9%) 比例显著降低, <i>P</i>=0.016, 0.007。多因素Logistic回归分析显示, 造影剂用量是DN患者发生CIN的独立危险因素 (OR=1.688, <i>P</i>=0.001) , 而使用抗坏血酸及硫酸氢钠是CIN的独立保护因素 (OR=0.693, <i>P</i>=0.021) 。<b>结论</b>:对于早期糖尿病肾病患者行冠脉介入手术, 维生素C联合碳酸氢钠可以显著降低CIN的发生率, 有效保护肾脏功能, 值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%B3%96%E5%B0%BF%E7%97%85%E8%82%BE%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">糖尿病肾病;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%A2%B3%E9%85%B8%E6%B0%A2%E9%92%A0&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">碳酸氢钠;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%8A%97%E5%9D%8F%E8%A1%80%E9%85%B8&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">抗坏血酸;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *曹杰, E-mail:caojieman@163.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2017-12-30</p>

            </div>
                    <h1>Preventive effect of sodium bicarbonate combined Vit C on contrast-induced nephropathy in patients with early diabetic nephropathy undergoing PCI</h1>
                    <h2>
                    <span>ZHANG Peng</span>
                    <span>ZHANG Rui-ni</span>
                    <span>LI Fei</span>
                    <span>GAO Feng</span>
                    <span>CAO Jie</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Cardio-cerebral Vascular Specialist Ward, Affiliated Hospital of Yan'an University</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To explore preventive effect of sodium bicarbonate combined Vit C on contrast-induced nephropathy (CIN) in patients with early diabetic nephropathy (DN) undergoing percutaneous coronary intervention (PCI) . <b>Methods</b>:A total of 420 patients with coronary heart disease complicated early DN treated in our department from Sep 2014 to Jul 2016 were selected, randomly and equally divided into routine PCI group and combined treatment group (received sodium bicarbonate combined Vit C based on routine PCI group) .Levels of serum creatinine (SCr) , glomerular filtration rate (GFR) , creatinine clearance rate (Ccr) and blood urea nitrogen (BUN) after contrast use and incidence rate of CIN were measured, recorded and compared between two groups, and independent risk factors for CIN were analyzed. <b>Results</b>:After contrast use, compared with routine PCI group, there were significant reductions in levels of SCr[ (110.32±12.35) μmol/L vs. (100.30±9.73) μmol/L]and BUN[ (11.23±2.43) mmol/L vs. (7.16±3.14) mmol/L], and significant rise in GFR[ (30.67±9.56) ml·min<sup>-1</sup>·1.73 m<sup>-2</sup> vs. (37.26±7.69) ml·min<sup>-1</sup>·1.73 m<sup>-2</sup>]and Ccr[ (62.31±19.73) ml/min vs. (68.07±21.48) ml/min]in combined treatment group, <i>P</i>&lt;0.01 all;percentages of SCr rise ≥44.2μmol/L (6.7%vs. 1.9%) and SCr increase ≥25% (9.0% vs. 2.9%) significantly reduced in combined treatment group, <i>P</i>=0.016, 0.007. Multi-factor Logistic regression analysis indicated that contrast dose was independent risk factor for CIN in DN patients (OR=1.688, <i>P</i>=0.001) , while use of sodium bicarbonate combined Vit C was its independent protective factor (OR=0.693, <i>P</i>=0.021) . <b>Conclusion</b>:For patients with early DN undergoing PCI, sodium bicarbonate combined Vit C can significantly reduce incidence rate of CIN, effectively protect kidney function, which is worth extending.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Diabetic%20nephropathies&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Diabetic nephropathies;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Sodium%20bicarbonate&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Sodium bicarbonate;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Ascorbic%20acid&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Ascorbic acid;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    CAO Jie, E-mail: caojieman@163.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2017-12-30</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="34">随着心血管介入治疗的发展, 造影剂肾病 (contrast-induced nephropathy, CIN) 发生率逐渐升高, 逐渐成为医院获得性急性肾衰竭的主要病因之一。众多研究表明, 糖尿病合并肾功能不全是发生CIN的独立危险因素之一, 该人群使用碘造影剂后CIN的发生率可高达50%<citation id="60" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。如何防治CIN已成为医学界重点关注的问题之一。本研究通过探讨碳酸氢钠联合抗坏血酸在冠心病合并早期糖尿病肾病患者冠脉介入治疗中应用, 探讨其对于CIN的预防作用。</p>
                </div>
                <h3 id="35" name="35" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="36" name="36">1.1 一般资料</h4>
                <div class="p1">
                    <p id="37">选择2014年9月至2016年7月在延安大学附属医院心内科住院的冠心病合并早期糖尿病肾病患者420例, 男283例, 女137例, 年龄50～82 (73.15±10.02) 岁。早期糖尿病肾病的诊断标准为24h尿蛋白总量30～300mg, 血肌酐 (SCr) 低于基准线, 肾小球滤过率 (GFR) ≥90ml·min<sup>-1</sup>·1.73m<sup>-2</sup>, 均未用肾毒性药物<citation id="61" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。排除标准:对碘剂过敏, 恶性肿瘤, 急、慢性感染, 急性肾衰竭, 肝硬化, 近期已行冠脉造影。</p>
                </div>
                <h4 class="anchor-tag" id="38" name="38">1.2 研究方法</h4>
                <div class="p1">
                    <p id="39">入组患者被随机均分为联合治疗组和常规介入组 (各210例) , 两组均予以行冠脉介入术, 术中均应用6F造影导管、非离子型低渗型造影剂碘普罗胺注射液 (优维显370) 行冠脉造影检查。常规介入组术前6～15h及术中应用0.9%氯化钠注射液1.5ml·kg<sup>-1</sup>·h<sup>-1</sup>静滴, 术后加量至2.5 ml·kg<sup>-1</sup>·h<sup>-1</sup>静滴6h, 液体总量控制在1500～2500ml。联合治疗组在常规介入组同样水化方法的基础上, 术前6～15h及术中给予1.25%碳酸氢钠20ml联合抗坏血酸3g静滴, 术后给予抗坏血酸4g静滴。比较两组一般临床资料, 包括人口基线资料、肾功能、合并症、药物治疗、造影剂用量、水化治疗等。检测SCr、尿素氮水平变化, 观察肾功能。CIN定义为造影后2～3d升高25%以上或SCr绝对值较造影前上升≥44.2μmol/L<citation id="62" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.3 检测方法</h4>
                <div class="p1">
                    <p id="41">清晨空腹条件下经肘静脉抽取患者的静脉血2ml, 置于含抗凝剂的真空采血管中, 3000r/min离心10min, 取上层血清, 使用罗氏R800全自动生化分析仪分别检测SCr、尿素氮 (BUN) 等水平。</p>
                </div>
                <h4 class="anchor-tag" id="42" name="42">1.4 统计学处理</h4>
                <div class="p1">
                    <p id="43">应用SPSS 17.0软件进行统计学分析, 计量资料以均数±标准差<mathml id="44"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。多因素分析采用Logistic回归方法, <i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="45" name="45" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="46" name="46">2.1 两组一般临床资料比较</h4>
                <div class="p1">
                    <p id="47">两组年龄、性别、人体质量指数 (BMI) 、SCr、肾小球滤过率 (GFR) 、肌酐清除率 (Ccr) 、BUN、血红蛋白、左室射血分数 (LVEF) 、高血压病、高脂血症比例、血管紧张素转化酶抑制剂/血管紧张素受体拮抗剂 (ACEI/ARB) 、利尿剂、他汀使用率、造影剂用量、水化生理盐水用量、术前水化时间均无统计学差异 (<i>P</i>均&gt;0.05) 。应用造影剂后, 与常规介入组比较, 联合治疗组SCr和BUN水平显著降低, GFR、Ccr水平显著升高 (<i>P</i>均&lt;0.01) 。联合治疗组SCr升高≥44.2μmol/L和升高≥25%的比例显著低于常规介入组 (<i>P</i>=0.016, 0.007) 。见表1～3。</p>
                </div>
                <div class="area_img" id="48">
                    <p class="img_tit"><b>表</b>1 <b>两组患者一般资料比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="48" border="1"><tr><td><br /></td><td>常规介入组<br /> (210例) </td><td>联合治疗组<br /> (210例) </td><td><i>t</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />年龄 (岁) </td><td>73.51±10.10</td><td>72.92±9.83</td><td>0.607</td><td>0.544</td></tr><tr><td><br />女性<i>n</i> (%) </td><td>69 (32.86) </td><td>75 (35.71) </td><td>0.380</td><td>0.537</td></tr><tr><td><br />人体质量指数 (kg/m<sup>2</sup>) </td><td>23.72±4.51</td><td>24.14±4.63</td><td>0.942</td><td>0.347</td></tr><tr><td><br />肌酐清除率 (μmol/L) </td><td>104.32±12.35</td><td>105.63±10.82</td><td>1.156</td><td>0.248</td></tr><tr><td><br /> GFR (ml·min<sup>-1</sup>·1.73m<sup>-2</sup>) </td><td> 39.37±8.26</td><td>35.62±9.54</td><td>1.039</td><td>0.299</td></tr><tr><td><br />血肌酐 (ml/min) </td><td>72.51±23.40</td><td>70.61±25.14</td><td>0.802</td><td>0.423</td></tr><tr><td><br />血尿素氮 (mmol/L) </td><td>6.95±3.37</td><td>7.03±2.87</td><td>0.262</td><td>0.793</td></tr><tr><td><br />血红蛋白 (g/dl) </td><td>12.31±2.34</td><td>12.42±4.35</td><td>0.323</td><td>0.747</td></tr><tr><td><br />左室射血分数 (%) </td><td>54.91±13.23</td><td>55.24±14.62</td><td>0.243</td><td>0.808</td></tr><tr><td><br />高血压病<i>n</i> (%) </td><td>185 (88.10) </td><td>180 (85.71) </td><td>0.523</td><td>0.470</td></tr><tr><td><br />高脂血症<i>n</i> (%) </td><td>137 (65.24) </td><td>145 (69.05) </td><td>0.691</td><td>0.406</td></tr><tr><td><br />ACEI/ARB <i>n</i> (%) </td><td>122 (58.10) </td><td>136 (64.76) </td><td>1.970</td><td>0.160</td></tr><tr><td><br />利尿剂 <i>n</i> (%) </td><td>81 (38.57) </td><td>76 (36.19) </td><td>0.254</td><td>0.614</td></tr><tr><td><br />他汀 <i>n</i> (%) </td><td>134 (63.81) </td><td>143 (68.10) </td><td>0.859</td><td>0.354</td></tr><tr><td><br />造影剂用量 (ml) </td><td>103.23±58.10</td><td>105.45±51.64</td><td>0.414</td><td>0.679</td></tr><tr><td><br />水化盐水用量 (ml) </td><td>2146.52±386.23</td><td>2178.21±413.30</td><td>1.178</td><td>0.239</td></tr><tr><td><br />术前水化时间 (h) </td><td>11.31±3.57</td><td>10.75±4.31</td><td>0.316</td><td>0.752</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:GFR:肾小球滤过率, ACEI/ARB:血管紧张素转化酶抑制剂/血管紧张素受体拮抗剂。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="49">
                    <p class="img_tit"><b>表</b>2 <b>应用造影剂后两组肾功能水平比较</b><mathml id="50"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="49" border="1"><tr><td><br /></td><td>常规介入组<br /> (210例) </td><td>联合治疗组<br /> (210例) </td><td><i>t</i>/<i>P</i></td></tr><tr><td><br />SCr (μmol/L) </td><td>110.32±12.35</td><td>100.30±9.73<sup>△△</sup></td><td>9.235/0.001</td></tr><tr><td><br />GFR (ml·min<sup>-1</sup>·1.73m<sup>-2</sup>) </td><td>30.67±9.56</td><td>37.26±7.69<sup>△△</sup></td><td>7.784/0.001</td></tr><tr><td><br />Ccr (ml/min) </td><td>62.31±19.73</td><td>68.07±21.48<sup>△△</sup></td><td>2.862/0.004</td></tr><tr><td><br />BUN (mmol/L) </td><td>11.23±2.43</td><td>7.16±3.14<sup>△△</sup></td><td>14.855/.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:SCr:肌酐清除率, eGFR:肾小球滤过率, Ccr:肌酐清除率, BUN:尿素氮。与常规介入组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="51">
                    <p class="img_tit"><b>表</b>3 CIN<b>发生率比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="51" border="1"><tr><td><br /></td><td>常规介入组<br /><i>n</i> (%) </td><td>联合治疗组<br /><i>n</i> (%) </td><td><i>χ</i><sup>2</sup>/<i>P</i></td></tr><tr><td><br />SCr升高≥44.2μmol/L</td><td>14 (6.7) </td><td>4 (1.9) <sup>△</sup></td><td>5.804/0.016</td></tr><tr><td><br />SCr升高≥25%</td><td>19 (9.0) </td><td>6 (2.9) <sup>△△</sup></td><td>7.188/0.007</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:CIN:造影剂肾病。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="52" name="52">2.2 Logistic单因素回归分析</h4>
                <div class="p1">
                    <p id="53">Logistic单因素回归分析显示, 未使用抗坏血酸联合碳酸氢钠、造影剂用量、生理盐水水化时间均是CIN的影响因素 (OR=1.014～6.401, <i>P</i>&lt;0.05或&lt;0.01) 。Logistic多元回归分析显示, 造影剂用量为CIN的独立危险因素 (OR=1.688, <i>P</i>=0.001) , 而使用抗坏血酸及碳酸氢钠是CIN的独立保护因素 (OR=0.693, <i>P</i>=0.021) 。见表4。</p>
                </div>
                <div class="area_img" id="54">
                    <p class="img_tit"><b>表</b>4 CIN<b>的多因素</b>Logistic<b>回归分析</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="54" border="1"><tr><td><br /></td><td>B</td><td>S.E.</td><td>Wald <i>χ</i><sup>2</sup></td><td>OR</td><td>95%CI</td><td><i>P</i></td></tr><tr><td><br />造影剂用量</td><td>0.523</td><td>0.133</td><td>15.375</td><td>1.688</td><td>1.299～2.192</td><td>0.001</td></tr><tr><td><br />使用抗坏血酸及碳酸氢钠</td><td>-0.367</td><td>0.159</td><td>5.337</td><td>0.693</td><td>0.507～0.946</td><td>0.021</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="55" name="55" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="56">近年来随着碘造影剂在心血管介入中应用日益广泛, 随之引发的CIN受到越来越多的重视, CIN是指在血管造影后新发的或是加重的肾功能损坏。一般人群CIN发生率较低, 而高危患者显著增加, 最高可达90%以上<citation id="63" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>。导致CIN的危险因素包括患者原有肾损害、糖尿病、高血压、代谢综合征、高龄、使用肾毒性药物等, 其中糖尿病肾病患者发生CIN的风险最高<citation id="64" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。糖尿病肾病是糖尿病的主要微血管并发症, 弥漫性肾基底膜增厚、系膜扩张和白蛋白、补体、纤维蛋白原沉积于肾小球不同部位均可挤压毛细血管袢, 导致GFR下降, 高血糖对肾小球内皮细胞的损伤增加了患者对造影剂的敏感性, 均使得CIN发生率升高<citation id="65" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。临床医生必须高度关注此问题, 并进行有效的措施进行干预进而降低CIN的发生率。本研究通过研究碳酸氢钠联合抗坏血酸在早期糖尿病肾病患者冠脉介入治疗中对CIN的预防作用。</p>
                </div>
                <div class="p1">
                    <p id="57">本研究通过比较两组肾功能水平, 发现碳酸氢钠联合抗坏血酸可以显著降低SCr和BUN水平, 改善肾功能, 进而降低CIN的发生率。碳酸氢钠通过提高肾局部pH值至偏中性或碱性, 减少自由基的产生, 减轻对肾脏的损坏, 并且碳酸氢钠使的肾脏血流得到充分改善, 同时碱化尿液, 减少Tamm-Horsfall蛋白及尿酸的产生, 减轻肾小管损坏<citation id="69" type="reference"><link href="17" rel="bibliography" /><link href="19" rel="bibliography" /><sup>[<a class="sup">7</a>,<a class="sup">8</a>]</sup></citation>。Nieto-Rios JF等<citation id="66" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>发现单独碳酸氢钠水化与生理盐水水化在预防CIN方面疗效无显著差异, 但有缩短输液时间, 减少补给量等优点。近年来研究发现, 抗坏血酸具有强效水溶性抗氧化特性, 能有效清除对脂类、核酸、蛋白质等大分子有损伤的多种氧自由基<citation id="67" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。在预防CIN方面, 国外许多研究表明, 抗坏血酸可减轻肾小管坏死程度、降低肾组织脂质过氧化产物丙二醛浓度, 避免氧化应激损伤, 并且可降低冠脉介入术后SCr的升高<citation id="70" type="reference"><link href="25" rel="bibliography" /><link href="28" rel="bibliography" /><link href="30" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>,<a class="sup">13</a>]</sup></citation>。 Komiyama K等<citation id="68" type="reference"><link href="32" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>发现碳酸氢钠联合抗坏血酸在慢性肾衰患者预防CIN发生中具有协同效应, 可显著降低CIN发生率, 与本研究结果相同。</p>
                </div>
                <div class="p1">
                    <p id="58">本研究通过Logistic单因素回归分析表明, 使用抗坏血酸联合碳酸氢钠、造影剂用量、生理盐水水化时间均是CIN的影响因素 (OR=1.027～1.056, <i>P</i>均&lt;0.01) 。Logistic多元回归分析提示造影剂用量为CIN的独立危险因素 (OR=1.688, <i>P</i>=0.001) , 而使用抗坏血酸及碳酸氢钠是CIN的独立保护因素 (OR=0.693, <i>P</i>=0.021) 。造影剂引起CIN的病理机制主要表现在: (1) 脊髓氧供应和氧需求之间失平衡; (2) 肾小球膜细胞对造影剂的特殊敏感性; (3) 缺血所致上皮细胞损伤及造影剂对上皮细胞的直接毒性作用; (4) 肾小管阻塞; (5) 肾小管内微栓子形成<citation id="71" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。根据本研究结果, 糖尿病肾病患者发生CIN的影响因素众多, 对于此类高危患者行冠脉介入手术, 推荐使用抗坏血酸联合碳酸氢钠预防CIN, 高龄患者需慎用造影剂, 术中尽可能减少造影剂用量, 术前及术中尽可能延长生理盐水水化时间, 最大程度降低CIN的发生率。</p>
                </div>
                <div class="p1">
                    <p id="59">综上所述, 对于糖尿病肾病患者行冠脉介入手术, 围手术期在最大程度减少造影剂用量和常规生理盐水水化的基础上, 加用抗坏血酸联合碳酸氢钠干预可以降低CIN的发生率, 有效保护肾脏功能, 比生理盐水水化能更有效地预防CIN的发生。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Removal of contrast media by different extracorporeal treatments">

                                <b>[1]</b>Schindler R, Stahl C, Venz S, et al.Removal of contrast media by different extracororeal treatments[J].Nephrol Dial Transplant, 2001, 16 (7) ;1471-1474.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201024034&amp;v=MTcwODZxZlp1Wm1GeWpsVjc3Skx6VFNZckc0SDlIT3E0OUdZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>王华平, 刘金华, 任强.糖化血红蛋白和尿微量清蛋白与糖尿病肾病关系的探讨[J].检验医学与临床, 2010, 7 (24) :2747-2748.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HNZD201009002&amp;v=MTMzODJQUmFyRzRIOUhNcG85RlpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWNzdKTFM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>冯霞.造影剂肾病发病机制及防治研究进展[J].中华实用诊断与治疗杂志, 2010, 24 (9) :835-837.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK121016052293&amp;v=MTEyMDFpZmNaYks2SDlITnFZOUFadWtHRHhNOHp4VVNtRGQ5U0g3bjN4RTlmYnZuS3JpZlplWnZGeW50VTcvSUpGOFZO&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>Toprak O.Risk Markers for Contrast-induced Nephropathy[J].Am J Med Sci, 2007, 334 (4) :283-290.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK698AAFD2C398103818A43985DAA5EE91&amp;v=MDM4NDlMVTA1dEJoeExpN3dhaz1OaWZjWmJXeEZxQzkyZnRIRitnR0JIMDV6QjRTNGs1NVMzYnFxV1pFQ0xmaE1MT2VDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>Kumar S, Nair RK, Aggarwal N, et al.Risk factors for contrast-induced nephropathy after coronary angiography[J].Saudi J Kidney Dis Transpl, 2017, 28 (2) :318-324.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Contrast-induced acute kidney injury and diabetic nephropathy">

                                <b>[6]</b>Calvin AD, Misra S, Pflueger A.Contrast-induced acute kidney injury and diabetic nephropathy[J].Nat Rev Nephrol, 2010, 6 (11) :679-688.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWKF1D8D075A17306AA9D4BDA2CB6BD5015&amp;v=MTU5Mjk0aEFGZW9JRDN3L3ZtY2FuanNQUEE3ZzMyQXpDOGFSUmJ1YUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTd3YWs9TmlmY1pjVzVhdG00cg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>Huber W, Huber T, Baum S, et al.Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline:A Randomized Controlled Trial[J].Medicine (Baltimore) , 2016, 95 (21) :e3720.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy:a systematic review and metaanalysis">

                                <b>[8]</b>Zapata-Chica CA, Bello Marquez D, Serna-Higuita LM, et al.Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy:a systematic review and meta-analysis[J].Colomb Med (Cali) , 2015, 46 (3) :90-103.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study)">

                                <b>[9]</b>Nieto-Rios JF, Salazar WA, Sánchez OM, et al.Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) [J].J Bras Nefrol, 2014, 36 (3) :360-366.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Action of ascorbic acid as a scavenger of active and stable oxygen radicals">

                                <b>[10]</b>Niki E.Action of ascorbic acid as a scavenger of active and stable oxygen radicals[J].Am J Clin Nutr, 1991, 54 (6Suppl) :1119s-1124s.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD13082100010207&amp;v=MTcxNTA5RlpPb1BEbncrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0UWF4TT1OaWZjYXJLN0h0bk9ybw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Dvoršak B, Kani<mathml id="27"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mover><mstyle mathsize="140%" displaystyle="true"><mtext>c</mtext></mstyle><mo>ˇ</mo></mover><mspace width="0.25em" /><mtext>V</mtext><mo>, </mo><mtext>E</mtext><mtext>k</mtext><mtext>a</mtext><mtext>r</mtext><mtext>t</mtext><mspace width="0.25em" /><mtext>R</mtext></mrow></math></mathml>, et al.Ascorbic Acid for the prevention of contrast- induced nephropathy after coronary angiography in patients with chronic renal impairment:a randomized controlled trial[J].Ther Apher Dial, 2013, 17 (4) :384-390.
                            </a>
                        </p>
                        <p id="28">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJIH&amp;filename=SJIH15082600301405&amp;v=MjU5NDlycVFUTW53WmVadEZpbmxVcmZJSUY0UWF4TT1OaWZDWnJLOUh0bk9xWTlGWitzT0NIdzhvQk1UNlQ0UFFIL2lyUmRHZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>Cetin M, Devrim E, Serin Kiliçoglu S, et al.Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue:partial protective role of ascorbic acid[J].Ren Fail, 2008, 30 (5) :567-572.
                            </a>
                        </p>
                        <p id="30">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000031523&amp;v=Mjk5OTNiSzZIOUhQcjQ5RlpPZ09DWDQ2b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0UWF4TT1OaWZjWg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Spargias K, Alexopoulos E, Kyrzopoulos S, et al.Ascorbic acid prevents contrast- mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J].Circulation, 2004, 110 (18) :2837-2842.
                            </a>
                        </p>
                        <p id="32">
                            <a id="bibliography_14" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Sodium bicarbonate-ascorbic acid combination for prevention of contrast-induced nephropathy in chronic kidney disease patients undergoing catheterization">

                                <b>[14]</b>Komiyama K, Ashikaga T, Inagaki D, et al.Sodium Bicarbonate-Ascorbic Acid Combination for Prevention of Contrast-Induced Nephropathy in Chronic Kidney Disease Patients Undergoing Catheterization[J].Circ J, 2017, 81 (2) :235-240.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903019" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903019&amp;v=MTMxNjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVjc3SlBUWE1aYkc0SDlqTXJJOUViWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
